We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+39.52%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$866M
AUM Growth
-$31.6M
(-3.5%)
Cap. Flow
-$181M
Cap. Flow
% of AUM
-20.86%
Top 10 Holdings %
Top 10 Hldgs %
11.15%
Holding
394
New
126
Increased
23
Reduced
100
Closed
121
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moog Inc Class A
MOG.A
|
+$8.18M |
| 2 |
Golar LNG
GLNG
|
+$6.78M |
| 3 |
Modine Manufacturing
MOD
|
+$6.63M |
| 4 |
MYR Group
MYRG
|
+$6.49M |
| 5 |
Dana Inc
DAN
|
+$6.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Credo Technology Group
CRDO
|
+$11.3M |
| 2 |
SNDK
Sandisk
SNDK
|
+$8.28M |
| 3 |
Madrigal Pharmaceuticals
MDGL
|
+$7.48M |
| 4 |
Lumentum
LITE
|
+$7.28M |
| 5 |
Guardant Health
GH
|
+$7.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 23.17% |
| 2 | Technology | 23.07% |
| 3 | Healthcare | 17.28% |
| 4 | Energy | 12.86% |
| 5 | Consumer Discretionary | 6.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Taysha Gene Therapies
TSHA
$1.6B
| – | – |
-823,758
| Closed | -$4.53M |
|
377
Travere Therapeutics
TVTX
$5.31B
| – | – |
-109,404
| Closed | -$4.18M |
|
378
Urban Outfitters
URBN
$6.05B
| – | – |
-52,441
| Closed | -$3.95M |
|
379
UroGen Pharma
URGN
$2.05B
| – | – |
-160,412
| Closed | -$3.76M |
|
380
US Gold Corp
USAU
$221M
| – | – |
-44,974
| Closed | -$873K |
|
381
Universal Insurance Holdings
UVE
$1.16B
| – | – |
-132,567
| Closed | -$4.48M |
|
|
VSXY
382
Victoria's Secret
VSXY
$6.7B
| – | – |
-93,058
| Closed | -$5.04M |
|
|
VTYX
383
DELISTED
Ventyx Biosciences
VTYX
| – | – |
-111,398
| Closed | -$1.01M |
|
384
Wayfair
W
$11.3B
| – | – |
-57,521
| Closed | -$5.78M |
|
385
GeneDx Holdings
WGS
$1.85B
| – | – |
-24,249
| Closed | -$3.15M |
|
386
Willdan Group
WLDN
$1.11B
| – | – |
-28,282
| Closed | -$2.93M |
|
387
Wave Life Sciences
WVE
$1.12B
| – | – |
-248,815
| Closed | -$4.23M |
|
388
WidePoint Corp
WYY
$108M
| – | – |
-98,066
| Closed | -$527K |
|
389
Xeris Biopharma Holdings
XERS
$1.44B
| – | – |
-80,154
| Closed | -$629K |
|
390
Xometry
XMTR
$4.78B
| – | – |
-92,853
| Closed | -$5.52M |
|
391
Zumiez
ZUMZ
$323M
| – | – |
-41,866
| Closed | -$1.09M |
|
392
Zurn Elkay Water Solutions
ZWS
$8.1B
| – | – |
-155,011
| Closed | -$7.21M |
|
|
RAPP
393
Rapport Therapeutics
RAPP
$1.98B
| – | – |
-85,555
| Closed | -$2.6M |
|
|
GRAL
394
GRAIL Inc
GRAL
$2.94B
| – | – |
-29,692
| Closed | -$2.54M |
|
Similar funds
NEPWA
RWM
MCM
HP
OMG
RB
BGC
ICCFIA
EAM Investors's Q1 2026 Portfolio in Review
As of Q1 2026, EAM Investors held 394 positions worth $866M, down 3.5% from $898M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
EAM Investors withdrew a net $181M in Q1 2026, closing 121 positions and reducing 100 holdings. Its most notable exit was Credo Technology Group, an estimated $11.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.
Against the trend, EAM Investors opened a new position in Moog Inc Class A worth $7.82M.
- EAM Investors's largest Q1 2026 buy was Moog Inc Class A: 26,715 shares worth $7.82M.
- EAM Investors added most to Bloom Energy in Q1 2026, an estimated $3.21M increase.
- EAM Investors's biggest Q1 2026 reduction was Sandisk, cutting an estimated $8.28M.
- EAM Investors fully exited Credo Technology Group in Q1 2026, selling an estimated $11.3M.
- EAM Investors's ten largest holdings make up 11% of its $866M portfolio in Q1 2026.
- EAM Investors opened 126 new positions and closed 121 in Q1 2026.
- EAM Investors's portfolio value fell 3.5% quarter-over-quarter to $866M.
Based on EAM Investors's 13F filing for Q1 2026, filed 13 May 2026.